the danazol study group

No ORCID on file · 1 paper in corpus · active 2016

Study types

  • letter 1
letter 2016
Potential beneficial effect of low‐dose danazol in combination with renin–angiotensin system inhibitors in diabetic macular oedema
·doi:10.1111/aos.13318

Although intra-ocular antivascular endothelial growth factor (VEGF) injections are the standard of care for patients with diabetic macular oedema (DME), some fail this treatment. This begets the need for alternative therapies for these pati…